Cargando…

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study

Background: Non-alcoholic fatty liver disease (NAFLD) is not uncommon in non-obese subjects, referred to as non-obese NAFLD. It is not fully determined whether non-obese NAFLD is associated with increased risks of type 2 diabetes (T2D) and coronary artery disease (CAD) in Chinese. This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Wen, Zhang, Ziyu, Zhao, Shuiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417689/ https://www.ncbi.nlm.nih.gov/pubmed/34490362 http://dx.doi.org/10.3389/fcvm.2021.680664

Ejemplares similares

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Gender-Based Association of Coronary Artery Calcification and Framingham Risk Score With Non-alcoholic Fatty Liver Disease and Abdominal Obesity in Taiwanese Adults, a Cross-Sectional Study
por: Tsou, Meng-Ting, et al.
Publicado: (2022)

Association of mean arterial pressure with non-alcoholic fatty liver disease: results from the NAGALA study
por: Li, Xinghui, et al.
Publicado: (2023)

Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

Oxidized Lipids: Common Immunogenic Drivers of Non-Alcoholic Fatty Liver Disease and Atherosclerosis
por: Hoebinger, Constanze, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
por: Song, Qi-Rui, et al.
Publicado: (2022)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study
por: Choi, JungMin, et al.
Publicado: (2022)

Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients
por: Wang, Zhe, et al.
Publicado: (2022)

Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
por: Liu, Jie, et al.
Publicado: (2022)

Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
por: Wang, Meng, et al.
Publicado: (2022)

Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension
por: Catena, Cristiana, et al.
Publicado: (2022)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Coronary functional assessment in non-obstructive coronary artery disease: Present situation and future direction
por: Zhai, Changlin, et al.
Publicado: (2022)

Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease
por: Baharvand-Ahmadi, Babak, et al.
Publicado: (2016)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

The Emerging Role of Long Non-coding RNAs and Circular RNAs in Coronary Artery Disease
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

D-Dimer Is Associated With Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease and Preserved Ejection Fraction
por: Lin, Yan, et al.
Publicado: (2022)

Case Report: Invasive and Non-invasive Hemodynamic Assessment of Coronary Artery Disease: Strengths and Weaknesses
por: Gajanan, Ganesh, et al.
Publicado: (2022)

Regional difference in the susceptibility of non-alcoholic fatty liver disease in China
por: Xia, Mingfeng, et al.
Publicado: (2020)

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease
por: Ghevariya, Vishal, et al.
Publicado: (2014)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

OR24-01 Characteristics Of Patients With Type 1 Or 2 Diabetes And Non-alcoholic Fatty Liver Disease: A Retrospective Cohort Study
por: Liu, Anna, et al.
Publicado: (2023)

Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study
por: Vink, Caitlin E. M., et al.
Publicado: (2021)

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

Incremental value of non-invasive myocardial work for the evaluation and prediction of coronary microvascular dysfunction in angina with no obstructive coronary artery disease
por: Li, Ying, et al.
Publicado: (2023)

The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease
por: Zhao, Xinyue, et al.
Publicado: (2021)

Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Saokaew, Surasak, et al.
Publicado: (2021)

Myocardial infarction with non-obstructive coronary arteries (MINOCA)
por: Yildiz, Mehmet, et al.
Publicado: (2022)

Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work
por: Sabatino, Jolanda, et al.
Publicado: (2021)

Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
por: McChord, Johanna, et al.
Publicado: (2023)

Determinants of Non-calcified Low-Attenuation Coronary Plaque Burden in Patients Without Known Coronary Artery Disease: A Coronary CT Angiography Study
por: Yamaura, Hiroki, et al.
Publicado: (2022)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
por: Choi, Ji Min, et al.
Publicado: (2022)

A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population
por: Oladunjoye, Olubunmi, et al.
Publicado: (2021)

New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
por: Cazac, Georgiana-Diana, et al.
Publicado: (2022)

Evaluation of 71 Coronary Artery Disease Risk Variants in a Multiethnic Cohort
por: Ke, Wangjing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_62c3b9ip5h53utd6osboajsk65